Company / Net Income
Twist Bioscience Corp Net Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$77.7M
FY2025
5-year range
-$217.9M / -$77.7M
FY2021-FY2025
Trend
+62.8%
vs FY2024
Sector context
#93 of 214
Health Care
What the data says
At -$78M, Twist Bioscience Corp's net income ranks #93 of 214 in the Health Care sector. Net Income has fluctuated over the past 9 years, ranging from -$218M in FY2022 to -$59M in FY2017.
Based on SEC 10-K filings.
-$78M in FY2025.
Improved from -$205M to -$78M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 214 in Health CareTop 43% of 214This company -$77.7M Sector average $443.1M
▼
-117.5% below sector average
Key checks
Key Insights
- In FY2025, net income increased 62.8% year-over-year.
- Ranks #93 out of 214 companies in the Health Care sector.
- Peak net income was recorded in FY2017.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$77.7M | +62.8% |
| FY2024 | -$208.7M | -2.0% |
| FY2023 | -$204.6M | +6.1% |
| FY2022 | -$217.9M | -43.2% |
| FY2021 | -$152.1M | -8.7% |
| FY2020 | -$139.9M | -30.0% |
| FY2019 | -$107.7M | -51.1% |
| FY2018 | -$71.2M | -20.1% |
| FY2017 | -$59.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026